Pure Global AI
NCT06326879Recruiting

A Comparative Study Between Early Onset Colorectal Cancer and Late Onset Colorectal Cancer Patients

Early-Onset Colorectal Cancer Versus Late-Onset Colorectal Cancer: a Prospective Observational Cohort Study to Explore the Clinical, Sociodemographic, Genetic, and Molecular Characteristics Associated With Adverse Oncological Outcomes (
Istituto Clinico HumanitasClinicalTrials.govother
Verified
Study focus
Disease/Condition
Colorectal Cancer
Drug/Device/Intervention
No intervention
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Istituto Clinico Humanitas
Location
Rozzano, Italy
Timeline & enrollment
Phase
N/A
Start date
Nov 30, 2023
End date
Oct 30, 2027
Enrollment
340 participants
Primary outcome

Incidence rate ratio of colorectal cancer recurrence

Summary

This study aims to investigate the clinical, socioeconomic, behavioral, genetic, and
 molecular factors characterizing Early Onset Colorectal Cancer (EOCRC) patients compared with
 Late Onset Colorectal Cancer (LOCRC) patients

ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Descending colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06326879
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06326879 through Pure Global AI's free database. This phase not specified trial is sponsored by Istituto Clinico Humanitas and is currently Recruiting. The study focuses on Colorectal Cancer. Target enrollment is 340 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.